Maryland to Accept NCDQS Accreditation for Licensing Requirements
The Maryland Board of Pharmacy became the4
th state to accept NCDQS QAS Accreditation or Inspection program as part of their licensing requirement as of their October 21, 2020, meeting.
If companies are not located in one of those 17 states, the applicant must hold Accreditation. Other than the NCDQS QAS Accreditation program, current Board-recognized accrediting programs include the Joint Commission, ACHC (Accreditation Commission for Home Care), NABP Drug Distributor Accreditation, and CHAP (Community Health Accreditation Program).
The Iowa Board of Pharmacy implemented their NABP Drug Distributor Accreditation (DDA, fka VAWD) in March 2020, after legislation was passed in 2018 (read our previous article on it here). However, Iowa began accepting NCDQS Accreditation as a part of a temporary waiver to the NABP DDA requirement, because timelines for NABP DDA could be so extensive, in some cases 24+ months even for reaccreditation.
Currently, Iowa is looking to codify this waiver through the rulemaking process (see Iowa rulemaking/public comments here). Of note is the industry push to have Iowa accept NCDQS QAS Accreditation as a full alternative to their NABP DDA requirement.
Kansas and Nebraska
Kansas and Nebraska Boards of Pharmacy currently accepts NCDQS QAS Inspection in lieu of a recent resident state license for out-of-state license applications.
To learn more about what these new rules mean for your business, please send us an email today at firstname.lastname@example.org!